Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial.

• Hoofdauteurs: Amir Javadi (Auteur), Ali Khamesipour (Auteur), Mohammad Ghoorchi (Auteur), Mahdieh Bahrami (Auteur), Alireza Khatami (Auteur), Iraj Sharifi (Auteur), Seyed Ebrahim Eskandari (Auteur), Alireza Fekri (Auteur), Mohamad Reza Aflatoonian (Auteur), Alireza Firooz (Auteur)
• Formaat: Boek
• Gepubliceerd in: Public Library of Science (PLoS), 2022-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Treatment of Cutaneous leishmaniasis (CL) is based on using antimoniate derivatives; patients' compliance for systemic injections is low due to the pain and systemic complications. In this randomized open trial, the efficacy of intra-lesional (IL) injections of meglumine antimoniate (MA) once a...